CPHI Milan: Beyond generics, how Indian pharma is rewriting its global playbook
At CPHI Milan, Indian pharma players are looking beyond traditional exports, using partnerships, licensing, CDMO, and differentiated products to expand their global footprint as geopolitical and supply-chain risks reshape the industry.
The Economic Times ·